Author: Georgi Momekov; Denitsa Momekova
Title: Ivermectin as a potential COVID-19 treatment from the pharmacokinetic point of view Document date: 2020_4_17
ID: 3hgmuyn4_16
Snippet: It has to be emphasized that general public communication of drugs as potential COVID-19 therapeutics, based solely on in vitro data, is neither scientifically nor ethically appropriate. Ivermectin has been previously shown to exert antiviral activity in vitro against Dengue fever virus (DENV) 33 , influenza virus 34 , West Nile Virus 35 , Venezuelan equine encephalitis virus 36 , and heralded as possible antiviral drug, but so far there has not .....
Document: It has to be emphasized that general public communication of drugs as potential COVID-19 therapeutics, based solely on in vitro data, is neither scientifically nor ethically appropriate. Ivermectin has been previously shown to exert antiviral activity in vitro against Dengue fever virus (DENV) 33 , influenza virus 34 , West Nile Virus 35 , Venezuelan equine encephalitis virus 36 , and heralded as possible antiviral drug, but so far there has not been any clinical translation of these data. Noteworthy a clinical trial for the treatment of Dengue fever in Thailand failed to show clinical benefits 11 . In light to the aforementioned pharmacokinetic considerations this is not surprising given the published inhibitory concentrations against DENV1-4 ranged 1.66 -2.32 µM 33 .
Search related documents:
Co phrase search for related documents- antiviral activity and clinical translation: 1, 2, 3
- antiviral activity and clinical trial: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33
- antiviral activity and Dengue fever: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16
- antiviral activity and Dengue fever virus: 1, 2, 3, 4, 5, 6, 7, 8
- antiviral activity and equine encephalitis: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
- antiviral activity and equine encephalitis virus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
- antiviral activity and fever virus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44
- antiviral activity and influenza virus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76
- antiviral activity and inhibitory concentration: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50
- antiviral activity and possible antiviral drug: 1, 2
- antiviral activity and potential therapeutic: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73
- antiviral activity and public communication: 1
- antiviral activity exert and influenza virus: 1, 2, 3, 4
- antiviral activity exert and potential therapeutic: 1, 2
- antiviral drug and clinical benefit: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
- antiviral drug and clinical translation: 1, 2, 3
- antiviral drug and clinical trial: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31
- antiviral drug and Dengue fever: 1, 2, 3, 4, 5, 6, 7
- antiviral drug and Dengue fever virus: 1, 2, 3, 4
Co phrase search for related documents, hyperlinks ordered by date